BioDrain Medical Lands Key Accounts In Minnesota And Michigan Expanding Its U.S. Market Share
BioDrain Medical Lands Key Accounts In Minnesota And Michigan Expanding Its U.S. Market ShareMINNEAPOLIS, Dec. 7, 2012 /PRNewswire/ -- BioDrain Medical, Inc., (OTCQB: BIOR), producer of the FDA cleared STREAMWAY System for automated surgical fluid disposal, announced today that it received purchase orders for STREAMWAY Systems in strategic markets including Minnesota and Michigan. In addition, BioDrain Medical has gained traction in Pennsylvania with its installation of trial units for surgical procedures at AAAHC (Accreditation Association for Ambulatory Health Care, Inc.), a well-renowned surgical facility.
BioDrain continues to enhance its presence in the automated surgical fluid disposal market.Josh Kornberg, Chief Executive Officer of BioDrain, commented on the recent accomplishments, stating, "This market continues to show us that customers are actively seeking alternatives to the products currently available. Our latest string of sales and installations is yet another significant step for BioDrain as we seek to build on our success in capturing U.S. market share.We have found that by establishing new customers that serve as reference sites in strategic locations, we dramatically improve our ability to sell into that geographic market".
About BioDrain Medical, Inc. BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Today's manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. BioDrain's STREAMWAY System fully automates the collection, measurement and disposal of surgical fluids and is designed to result in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving Occupational State and Health Association (OSHA) and other regulatory compliance agencies' safety concerns, and 3) streamlining the efficiency of the operating room (and thereby making surgeries more profitable).
BioDrain's STREAMWAY System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of BioDrain's STREAMWAY System, the number of canisters can be significantly reduced. BioDrain Medical, Inc. makes the operating room and our environment safer, cleaner, and better. BioDrain products are currently being represented by independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country. For additional information, please visit: www.biodrainmedical.com.
Forward-looking Statements: Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the company's ability to implement its long range business plan for various applications of its technology; the company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the company's most recent Quarterly Report on Form 10-Q and subsequent 8-K filings.